LightPath Technologies Secures $4.9 Million Order for Infrared Cameras With an Existing Defense Customer
UF startup LightPath Technologies, Inc., announced its subsidiary G5 Infrared, a leading high-end infrared camera systems manufacturer, received a $4.9 million follow-on order from an existing defense industry customer.
NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.
UF Startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with Summit Products Group, a national provider of advanced wound care solutions.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3–6
UF startup Rise Therapeutics announced that it will report its first clinical results from the completed dose escalation segment of its R-3750 Phase 1 clinical trial in ulcerative colitis at the upcoming DDW conference.
LightPath Technologies Secures $4.8 Million Qualification Order for Infrared Cameras With New Defense Customer
UF startup LightPath Technologies, Inc. announced that its recently acquired subsidiary G5 Infrared received a $4.8 million initial qualification order for infrared cameras from a new defense industry customer.
Scripps Institute Spin-Out Company Raises $3 Million
UF startup Myosin Therapeutics, a biotechnology company developing medications to treat brain cancer and methamphetamine addiction, secured $3 million in seed funding.
iOncologi, Inc. Acquires TargImmune Therapeutics To Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors
UF startup iOncologi announced the acquisition of TargImmune Therapeutics to enhance its capabilities in developing immunotherapies for solid tumors.
Myosin Therapeutics Closes Second Seed Round To Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies
UF startup Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding round, raising over $3 million to supplement significant investment from the National Institutes of Health.
LightPath Technologies Announces Closing of Acquisition of G5 Infrared LLC
UF startup LightPath Technologies, Inc. announced that it has completed the previously announced acquisition of G5 Infrared, LLC, a New Hampshire-based company specializing in infrared optical solutions.
Solid Biosciences Reports Positive Initial Clinical Data From Next-Generation Duchenne Gene Therapy Candidate SGT-003
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced positive initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy candidate for treating Duchenne muscular dystrophy.
